Medtronic CEO Geoff Martha told investors Tuesday that the company’s ablation business did not grow as expected last quarter ...

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The alliance positions GE Healthcare to distribute Radnet software designed to help mammography centers view images, ...

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...